Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a 18.600\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a) Cc1ccc2oc3c(c(=O)c2c1)C(c1cccc(O)c1)N(c1ccccn1)C3=O
b) Cc1nnc(NC(=O)CSc2ncnc3scc(-c4ccccc4)c23)s1
c) Cc1ccc(C)c(C(=O)COC(=O)CCCC(=O)Nc2cc(C(F)(F)F)ccc2Cl)c1
d) Cc1ccc(NCC(=O)N/N=C\c2ccc([N+](=O)[O-])o2)cc1
e) CCOc1ccc(-c2noc(COC)n2)cc1OC
Answer: b. Cc1nnc(NC(=O)CSc2ncnc3scc(-c4ccccc4)c23)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nnc(NC(=O)CSc2ncnc3scc(-c4ccccc4)c23)s1
Cc1nnc(NC(=O)CSc2ncnc3scc(-c4ccccc4)c23)s1
N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-(5-phenylthieno[2,3-d]pyrimidin-4-yl)sulfanylacetamide